- Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
Clinical trials
-
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease (20212063) -
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All